Delivery Order SPE2DR25D3005-SPE2DR26FP8EW
- Not listed
- The Defense Logistics Agency awarded a $7,387.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Arimidex 1 mg tablets, with a completion date of December 9, 2025. This is a non-set-aside contract issued competitively to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader contract vehicle with the Defense Logistics Agency. This delivery order is a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,389.99 on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 9, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's ability to compete in...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded a $4,776.45 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Arimidex 1 mg tablets (30-count units). This non-set-aside competitive award is scheduled for completion by December 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a $3,407.96 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed price contract, issued without set-aside designation, represents a competitively awarded order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,438.88 delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. The award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The pharmaceutical will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $6,074.30 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg, with an ultimate completion date of December 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The place of performance is listed in Conshohocken, Pennsylvania, where the vendor maintains its...
- The Defense Logistics Agency awarded a $7,520.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with an ultimate completion date of December 8, 2025. This non-set-aside competitive award was issued on December 5, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8EWDelivery Order
The Defense Logistics Agency awarded a $4,305.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-tablet bottles of Arimidex 1 mg tablets. This delivery order, with an ultimate completion date of December 29, 2025, represents a non-competitive award issued on December 26, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as both the place of performance and AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which is valued at $999.9 million through December 2026. As a prime vendor for DLA's global pharmaceutical support program, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other federal government agencies. The parent IDC enables flexible procurement of pharmaceutical products across multiple therapeutic domains to serve the Defense Health Agency, U.S. Coast Guard, and related healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/25/25 |